Patents by Inventor Christopher C. Glenn

Christopher C. Glenn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8609828
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: December 17, 2013
    Assignee: Bayer HealthCare LLC
    Inventors: Stefan H. M. Burde, Todd M. Gierman, Christopher C. Glenn
  • Publication number: 20110008768
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Application
    Filed: July 30, 2010
    Publication date: January 13, 2011
    Applicant: Bayer HealthCare LLC
    Inventors: Stefan H.M. Burde, Todd M. Gierman, Christopher C. Glenn
  • Patent number: 7795417
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Grant
    Filed: November 6, 2007
    Date of Patent: September 14, 2010
    Assignee: Bayer HealthCare LLC
    Inventors: Stefan H. M. Burde, Todd M. Gierman, Christopher C. Glenn
  • Patent number: 7385049
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: June 10, 2008
    Assignee: Bayer HealthCare LLC
    Inventors: Stefan H. M. Burde, Todd M. Gierman, Christopher C. Glenn